Correlation Between Mineralys Therapeutics, and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Pliant Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Pliant Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Pliant Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and Pliant is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Pliant Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.76 times more return on investment than Pliant Therapeutics. However, Mineralys Therapeutics, is 1.76 times more volatile than Pliant Therapeutics. It trades about -0.05 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 1,361 in Mineralys Therapeutics, Common on August 26, 2024 and sell it today you would lose (112.00) from holding Mineralys Therapeutics, Common or give up 8.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Pliant Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Pliant Therapeutics |
Mineralys Therapeutics, and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Pliant Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| Pliant Therapeutics vs. Eliem Therapeutics | Pliant Therapeutics vs. HCW Biologics | Pliant Therapeutics vs. Scpharmaceuticals | Pliant Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |